Targeted Therapies Emerge for Nonmelanoma Skin Cancer

Elsevier Global Medical News. 2010 May 21, B Jancin

MADRID (EGMN) - Targeted therapy - the glamour area of cancer research in recent years - has arrived at the doorstep of nonmelanoma skin cancer in a big way."There are at least 24 open trials of targeted therapies for nonmelanoma skin cancer listed now at www.clinicaltrials.gov," Dr. Gunther Hofbauer noted at the 13th World Congress on Cancers of the Skin, sponsored by the Skin Cancer Foundation.The mainstays of targeted cancer therapy are monoclonal antibodies and oral small molecules directed at...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration